Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Progenics Pharmaceuticals Inc. (PGNX)

4.245   -0.115 (-2.64%) 05-29 16:00
Open: 4.34 Pre. Close: 4.36
High: 4.4 Low: 4.17
Volume: 604,518 Market Cap: 368M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.516 - 4.532 4.532 - 4.546
Low: 4.206 - 4.227 4.227 - 4.243
Close: 4.329 - 4.361 4.361 - 4.386

Technical analysis

as of: 2020-05-29 3:59:10 PM
Overall:       
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 5.27     One year: 6.15
Support: Support1: 3.81    Support2: 3.38
Resistance: Resistance1: 4.51    Resistance2: 5.27
Pivot: 3.89
Moving Average: MA(5): 4.15     MA(20): 3.88
MA(100): 4.09     MA(250): 4.69
MACD: MACD(12,26): 0.10     Signal(9): 0.04
Stochastic oscillator: %K(14,3): 85.36     %D(3): 84.91
RSI: RSI(14): 57.45
52-week: High: 6.37  Low: 1.89  Change(%): 3.0
Average Vol(K): 3-Month: 85328  10-Days: 52332

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
PGNX has closed below upper band by 17.4%. Bollinger Bands are 21.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 28 May 2020
Progenics Pharmaceuticals Inc. (PGNX) Soars 1.63% on May 28 - Equities.com

Wed, 27 May 2020
SHAREHOLDER ALERT: WeissLaw LLP Investigates Progenics Pharmaceuticals, Inc. - PRNewswire

Thu, 07 May 2020
Progenics Pharmaceuticals Announces First Quarter 2020 Financial Results and Business Update - GlobeNewswire

Fri, 29 May 2020
NASDAQ:PGNX Investor Alert: Lawsuit Filed in Effort to Halt the Takeover of Progenics Pharmaceuticals, Inc. - Press Release - Digital Journal

Wed, 20 May 2020
Progenics Pharmaceuticals Inc. (PGNX) Soars 5.51% on May 20 - Equities.com

Wed, 13 May 2020
Progenics Pharmaceuticals Inc. (PGNX) Plunges 5.04% on May 13 - Equities.com

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 87
Shares Float (M) 68
% Held by Insiders 9.60
% Held by Institutions 76.10
Shares Short (K) 5,530
Shares Short P. Month (K) 5,860

Stock Financials

EPS -0.774
EPS Est This Year -0.900
EPS Est Next Year -0.360
Book Value (p.s.) 0.350
Profit Margin -180.28
Operating Margin -165.87
Return on Assets (ttm) -29.2
Return on Equity (ttm) -116.9
Qtrly Rev. Growth 45.9
Gross Profit (p.s.) 0.367
Sales Per Share 0.427
EBITDA (p.s.) -0.678
Qtrly Earnings Growth
Operating Cash Flow (M) -64
Levered Free Cash Flow (M) -54

Stock Valuations

PE Ratio -5.44
PEG Ratio
Price to Book value 12.03
Price to Sales 9.87
Price to Cash Flow -5.72

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.